Sarolaner
Sarolaner (brand name Simparica) is an ectoparasiticide veterinary drug for the treatment of flea and tick infestations in dogs.[1][2] It is also used off-label to control sarcoptic mange and demodectic mange.[2]
Clinical data | |
---|---|
Trade names | Simparica |
Other names | PF-6450567 |
ATCvet code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.234.000 |
Chemical and physical data | |
Formula | C23H18Cl2F4N2O5S |
Molar mass | 581.36 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Sarolaner is also a component of the combination drug Simparica Trio, which contains sarolaner, moxidectin, and pyrantel. It is used for prevention of heartworm disease caused by Dirofilaria immitis; treat and prevent flea infestations; treat and control tick infestations with the lone star tick, Gulf Coast tick, American dog tick, black-legged tick, and brown dog tick; and treat and control roundworm and adult hookworm infections.[3]
Sarolaner is also an ingredient in feline combination antiparasitic Revolution Plus (known as Stronghold Plus in some countries), which contains sarolaner and selamectin and is used for prevention of sarcoptic mange, feline hookworms, feline roundworms, ear mites, and heartworms, as well as treating and preventing fleas and ticks. Sarolaner is in the formulation to kill fleas, ear mites, and ticks.[4]
References
- McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590.
- Gollakner R. "Sarolaner". vcahospitals.com. VCA Hospitals. Retrieved June 26, 2021.
- "FDA Approves Simparica Trio, a Combination Drug for Heartworm and Other Parasites". Food and Drug Administration. March 2, 2020. Retrieved June 26, 2021.
- "About Revolution Plus". www.zoetisus.com. Retrieved 2022-05-27.